Pharmaceutical - Financial

Filter

Current filters:

Financial

Popular Filters

1 to 25 of 1088 results

Allergan says Pershing’s additional requests for meeting is not “meaningful development”

Allergan says Pershing’s additional requests for meeting is not “meaningful development”

15-09-2014

Hostile takeover target Allergan has said that value is what “really matters” in response to Pershing…

AllerganCanadaFinancialLegalPharmaceuticalUSAValeant Pharmaceuticals International

GSK joins with research councils in UK and South Africa to tackle non-communicable diseases in Africa

GSK joins with research councils in UK and South Africa to tackle non-communicable diseases in Africa

09-09-2014

UK pharma giant GlaxoSmithKline today announced a £5 million ($8.2 million) collaboration with the UK…

FinancialGlaxoSmithKlinePharmaceuticalResearchSouth AfricaUK

Ablynx launches American Depository Receipt program to expand US investor base

Ablynx launches American Depository Receipt program to expand US investor base

05-09-2014

Belgian drug developer Ablynx has launched a Sponsored Level I American Depository Receipt (ADR) program…

AblynxBusiness FinanceFinancialInvestmentPharmaceuticalStock marketUSA

Takeda and Lilly fail to overturn $9 billion award for hiding cancer risk of Actos

Takeda and Lilly fail to overturn $9 billion award for hiding cancer risk of Actos

31-08-2014

Japan’s largest drugmaker Takeda Pharmaceutical and US pharma major Eli Lilly have failed in their…

ActosDiabetesEli LillyFinancialLegalPharmaceuticalTakeda PharmaceuticalUSA

Ipsen posts strong earnings growth for first-half 2014

Ipsen posts strong earnings growth for first-half 2014

29-08-2014

French drugmaker Ipsen has reported first half 2014 sales of 638.7 million euros ($845.1 million), up…

FinancialIpsenPharmaceutical

Edison re-evaluates Onconova based on extended rigosertib timeline after trial failure

Edison re-evaluates Onconova based on extended rigosertib timeline after trial failure

29-08-2014

After failing to meet the primary endpoint of its trial of rigosertib (IV), oncology specialist Onconova…

FinancialMyelodysplastic syndromeOncologyOncology specialistOnconova TherapeuticsPharmaceuticalrigosertibUSA

Recipharm inks deal with Isofol Medical on Modufolin

Recipharm inks deal with Isofol Medical on Modufolin

26-08-2014

Swedish contract development and manufacturing group Recipharm and Isofol Medical AB, a Gothenburg-based…

FinancialIsofol MedicalModufolinOncologyPharmaceuticalProductionRecipharmResearch

US Administration to ensure women’s continued access to contraception coverage, while respecting religious-based objections

US Administration to ensure women’s continued access to contraception coverage, while respecting religious-based objections

25-08-2014

On Friday, the Obama Administration in the USA took several steps to help ensure women, whose coverage…

FinancialPharmaceuticalRegulationReproductiveUSA

Grattan Institute admission shows Australia’s PBS savings proposal was wrong

Grattan Institute admission shows Australia’s PBS savings proposal was wrong

21-08-2014

The Grattan Institute’s proposal on Australia Pharmaceutical Benefits Scheme (PBS) savings has been…

AustraliaFinancialPharmaceuticalPricing

Mood lifts for Medtech in first half of 2014, while Pharma sector faces new struggles

Mood lifts for Medtech in first half of 2014, while Pharma sector faces new struggles

20-08-2014

An M&A frenzy that accounted for nearly $90 billion of equity set the pace for the first half of 2014…

FinancialGlobalJonathan GardnerMergers & AcquisitionsPharmaceutical

Novo Nordisk accepts fine from Danish public prosecutor over financial disclosure

Novo Nordisk accepts fine from Danish public prosecutor over financial disclosure

18-08-2014

Danish insulin giant Novo Nordisk has accepted a fine of 500,000 kroner ($89,735), imposed by the Public…

CopenhagenDanish Financial Supervisory AuthorityDenmarkDiabetesFinancialNovo NordiskPharmaceutical

New Zealand to fund Vidaza and Revlimid

New Zealand to fund Vidaza and Revlimid

13-08-2014

New Zealand’s Pharmaceutical Management Agency PHARMAC says it has approved a proposal for funding…

Celgene Corp.FinancialHealthcareNew ZealandPharmaceuticalPricingRevlimidVidaza

Strong growth forecast for Saudi Arabia pharmaceuticals market

Strong growth forecast for Saudi Arabia pharmaceuticals market

13-08-2014

Pharmaceuticals products sales in Saudi Arabia are expected to exceed a value of $ 7 billion by 2018,…

Business FinanceFinancialMarkets & MarketingPharmaceuticalProductionRest of the WorldSaudi Arabia

ALK Abello reports strong improvement in 2nd-qtr financials

ALK Abello reports strong improvement in 2nd-qtr financials

13-08-2014

Denmark-based allergy specialist ALK Abello has reported significant progress in its sales for the second…

ALK AbelloDenmarkFinanceFinancialNorwegian kronePharmaceuticalRespiratory and Pulmonary

Merck KGaA 2nd-qtr earnings beat expectations

Merck KGaA 2nd-qtr earnings beat expectations

13-08-2014

German pharmaceuticals and chemicals major Merck KGaA said this morning that it has generated organic…

Business FinanceFinancialGermanyMerck KGaAMerck SeronoPharmaceutical

Boehringer Ingelheim sees 1st-half sales fall, but overcomes challenges

Boehringer Ingelheim sees 1st-half sales fall, but overcomes challenges

12-08-2014

German family-owned pharma major Boehringer Ingelheim reported first-half 2014 results, showing that…

Boehringer IngelheimChronic obstructive pulmonary disease therapyFinancialGermanyPharmaceutical

US federal drug discount program “faces challenges as it expands”

US federal drug discount program “faces challenges as it expands”

12-08-2014

A federal program that provides billions in drug discounts to safety net hospitals and other health care…

FinancialHealthHealth Medical PharmaHealthcarePharmaceuticalPharmaceutical industryPharmacologyRANDRegulationUSA

Prosensa and CureDuchenne expand DMD collaboration with $7 million funding boost

Prosensa and CureDuchenne expand DMD collaboration with $7 million funding boost

12-08-2014

Dutch biotech company Prosensa will receive a 5 million euros ($7 million) funding boost from US non-profit…

Duchenne Muscular DystrophyFinancialNetherlandsPharmaceuticalProsensaRare diseasesResearchUSA

US court orders SIGA to pay PharmAthene lump sum expectation damages

US court orders SIGA to pay PharmAthene lump sum expectation damages

11-08-2014

USA-based biodefense company PharmAthene says that, on Friday, the Delaware Court of Chancery issued…

Anti-viralsDelaware Court of ChanceryFinancialLegalPharmaceuticalPharmAtheneSIGA TechnologiesTecovirimatUSA

Multiple sclerosis treatments funding proposal in New Zealand

Multiple sclerosis treatments funding proposal in New Zealand

07-08-2014

New Zealand’s Pharmaceutical Management Agency PHARMAC is seeking feedback on a funding proposal involving…

Biogen IdecFinancialGilenyaNeurologicalNew ZealandNovartisPharmaceuticalTysabri

Novo Nordisk beats estimates as net profit grows 4%

Novo Nordisk beats estimates as net profit grows 4%

07-08-2014

Danish diabetes care giant Novo Nordisk released first-half 2014 financial results this morning, showing…

Business FinanceChief executiveDiabetesFinancialNOKNovo NordiskPeptide hormonesPharmaceuticalRecombinant proteins

Allergan attacks Valeant’s financial results

Allergan attacks Valeant’s financial results

06-08-2014

US Botox maker Allergan, the subject of a hostile $53 billion takeover attempt by Canada’s Valeant…

AllerganBusiness FinanceCanadaFinancialMergers & AcquisitionsPharmaceuticalUSAValeant PharmaceuticalsValeant Pharmaceuticals International

1 to 25 of 1088 results

Back to top